Game,

IMO the strategy you are following will keep you from buying stock until the results of the beta site study are known, if the results are statistically significant, the stock will move aggressively upward for a second time, which means if you choose to buy you will buy into a running share price. Of course, IMO if the study is negative or equivocal the share price will crater and you will have wisely avoided a catastrophe.

None of us knows what the outcome of the study and commercial launch (if there is one) will be but I have voted with my wallet and time will tell/reward me if I am correct.

Regards your statement "Steady corporate growth with solid revenue and profits over a long period would sustain a stocks price and continue growth if in fact what they make really has value." IMO this statement has no relevance to Cardiogenics as I believe once the probability of "solid revenue and proifits" becomes obvious/know, Cardiogenics will cease to exist as an independent company.

Ante